Oncolytic viruses facilitate the function of antigen-presenting cells (APCs), which migrate to the lymph nodes to activate the cytotoxic CD8+ T lymphocytes (CTLs) and recruit them to the infection site leading to tumor cell killing [41] (Figure 1). This evidence concerns the gene CD8A and neoplasm.